Business Information
- 1 May 2007
- journal article
- practice guideline
- Published by Elsevier BV in Endocrine Practice
- Vol. 13, 2-68
- https://doi.org/10.4158/ep.13.s1.1
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Rosiglitazone RECORD study: glucose control outcomes at 18 monthsDiabetic Medicine, 2007
- Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double‐blind, non‐inferiority trialDiabetes, Obesity and Metabolism, 2007
- Homocysteine Lowering with Folic Acid and B Vitamins in Vascular DiseaseNew England Journal of Medicine, 2006
- Assessing Glycemia in Diabetes Using Self-monitoring Blood Glucose and Hemoglobin A1cJAMA, 2006
- Prevalence of Silent Myocardial Ischemia in Persons With Diabetes Mellitus or Impaired Glucose Tolerance and Association of Hemoglobin A1c With Prevalence of Silent Myocardial IschemiaThe American Journal of Cardiology, 2005
- Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose‐timing studyDiabetes/Metabolism Research and Reviews, 2004
- Repaglinide in Type 2 Diabetes: A 24-Week, Fixed-Dose Efficacy and Safety StudyThe Journal of Clinical Pharmacology, 2000
- Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised studyThe Lancet, 1999
- Pramlintide: A Human Amylin Analogue Reduced Postprandial Plasma Glucose, Insulin, and C-peptide Concentrations in Patients with Type 2 DiabetesDiabetic Medicine, 1997
- First‐trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancyTeratology, 1989